IL296884B2
Substituted heterocycle fused gamma carbolines for use in the treatment of central nervous system disorders
Abstract
This record has no abstract on file.
Term
No projected expiry on record.
- Priority
- Filed
- Published
- Today
61 members in 17 offices
Priority claims5
| Document | Office | Kind | Date |
|---|---|---|---|
| 201662287264 | United States of America | P | |
| 62287264 | United States of America | – | |
| 201662440130 | United States of America | P | |
| 62440130 | United States of America | – | |
| 2017015178 | United States of America | W |
Members61
| Document | Office | Kind | |
|---|---|---|---|
| CA3011983A1 | Canada | A1 | |
| WO2017132408A1 | World Intellectual Property Organization (WIPO) | A1 | |
| US2017319580A1 | United States of America | A1 | |
| AU2017211791A1 | Australia | A1 | |
| KR20180099905A | Republic of Korea | A | |
| IL260653A | Israel | A | |
| MX2018009158A | Mexico | A | |
| CN108883111A | China | A | |
| EP3407888A1 | European Patent Office (EPO) | A1 | |
| BR112018015283A2 | Brazil | A2 | |
| JP2019503383A | Japan | A | |
| US10245260B2 | United States of America | B2 | |
| US2019175590A1 | United States of America | A1 | |
| EP3407888A4 | European Patent Office (EPO) | A4 | |
| RU2018130727A | Russian Federation | A | |
| RU2018130727A3 | Russian Federation | A3 | |
| US10799500B2 | United States of America | B2 | |
| RU2020134306A | Russian Federation | A | |
| EP3407888B1 | European Patent Office (EPO) | B1 | |
| RU2743513C2 | Russian Federation | C2 | |
| US2021060010A1 | United States of America | A1 | |
| PT3407888T | Portugal | T | |
| DK3407888T3 | Denmark | T3 | |
| EP3838274A1 | European Patent Office (EPO) | A1 | |
| HUE053737T2 | Hungary | T2 | |
| PL3407888T3 | Poland | T3 | |
| CN108883111B | China | B | |
| ES2863471T3 | Spain | T3 | |
| MX2021010306A | Mexico | A | |
| CN113786407A | China | A | |
| AU2017211791B2 | Australia | B2 | |
| RU2020134306A3 | Russian Federation | A3 | |
| JP6995761B2 | Japan | B2 | |
| JP2022050417A | Japan | A | |
| IL260653B | Israel | B | |
| IL296884A | Israel | A | |
| IL260653B2 | Israel | B2 | |
| JP7234337B2 | Japan | B2 | |
| JP2023075159A | Japan | A | |
| US2023181576A9 | United States of America | A9 | |
| BR112018015283B1 | Brazil | B1 | |
| EP3838274B1 | European Patent Office (EPO) | B1 | |
| PT3838274T | Portugal | T | |
| US11844757B2 | United States of America | B2 | |
| IL296884B1 | Israel | B1 | |
| DK3838274T3 | Denmark | T3 | |
| IL309536A | Israel | A | |
| PL3838274T3 | Poland | T3 | |
| JP7471482B2 | Japan | B2 | |
| HUE064667T2 | Hungary | T2 | |
| IL296884B2This record | Israel | B2 | |
| ES2969145T3 | Spain | T3 | |
| US2024165111A1 | United States of America | A1 | |
| CN113786407B | China | B | |
| KR102735964B1 | Republic of Korea | B1 | |
| KR20240170975A | Republic of Korea | A | |
| IL309536B1 | Israel | B1 | |
| IL318649A | Israel | A | |
| MX385678B | Mexico | B | |
| IL309536B2 | Israel | B2 | |
| US12440489B2 | United States of America | B2 |
Numbers
- Publication
- 296884
- Application
- 296884
Titles2
- English
- SUBSTITUTED HETEROCYCLE FUSED GAMMA CARBOLINES FOR USE IN THE TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS
- Hebrew
- גאמה קרבונילים דחוסים מותמרים בהטרוציקליים לשימוש בטיפול באי סדרים של מערכת העצבים המרכזית
Classification
- CPC, 19
- A61K31/4985
- C07D471/16
- A61K9/16
- A61K45/06
- A61K9/0019
- A61P25/30
- A61K31/445
- A61P25/28
- A61P25/18
- A61P25/00
- A61P25/24
- A61P25/22
- C07D241/40
- A61P15/00
- A61K45/00
- A61P25/32
- A61P25/36
- C07D471/14
- A61K9/1647
- IPC, 9
- C07D471 16
- A61P25 00
- A61K45 06
- A61K45 00
- A61K9 00
- A61K9 16
- A61K31 445
- A61K31 4985
- C07D241 40